Cost-effectiveness analysis of cholecystectomy during Roux-en-Y gastric bypass for morbid obesity
- PMID: 22938897
- PMCID: PMC3488959
- DOI: 10.1016/j.surg.2012.06.013
Cost-effectiveness analysis of cholecystectomy during Roux-en-Y gastric bypass for morbid obesity
Abstract
Background: Controversy exists regarding the use of concurrent cholecystectomy during Roux-en-Y gastric bypass performed for morbid obesity.
Methods: A decision model was developed to evaluate the cost-effectiveness of current strategies: routine concurrent cholecystectomy, Roux-en-Y gastric bypass alone with or without postoperative ursodiol therapy, and selective cholecystectomy based on preoperative findings on ultrasonography. Probabilities were obtained from a comprehensive literature review. Costs and hospital days were obtained from the Healthcare Cost and Utilization Project Nationwide Inpatient Sample. One-way sensitivity analyses were performed.
Results: The least expensive strategy was to perform RYGB alone without preoperative ultrasonography, with an average cost (over RYGB costs) of $537 per patient. RYGB with concurrent cholecystectomy had a cost of $631. Selective cholecystectomy based on preoperative ultrasonography was dominated by the other 2 strategies. Our model was most sensitive to the probability of developing gallbladder-related symptoms after RYGB alone. When the incidence of gallbladder-related symptoms was <4.6%, the dominant strategy was to perform a RYGB alone without preoperative ultrasonography. For values >6.9%, performing concurrent cholecystectomy at the time of the RYGB was superior to other strategies. When ursodiol was used, the least expensive strategy was to perform a concurrent cholecystectomy during RYGB.
Conclusion: The main factor determining the most cost-effective strategy is the incidence of gallbladder-related symptoms after RYGB. The use of ursodiol was associated with an increase in cost that does not justify its use after RYGB. Finally, selective cholecystectomy based on preoperative ultrasonography was dominated by the other strategies in the scenarios evaluated.
Published by Mosby, Inc.
Figures



Similar articles
-
Elective cholecystectomy after Roux-en-Y gastric bypass: why should asymptomatic gallstones be treated differently in morbidly obese patients?Surg Obes Relat Dis. 2005 Nov-Dec;1(6):555-60. doi: 10.1016/j.soard.2005.08.002. Epub 2005 Sep 28. Surg Obes Relat Dis. 2005. PMID: 16925290
-
Routine gallbladder screening not necessary in patients undergoing laparoscopic Roux-en-Y gastric bypass.Surg Obes Relat Dis. 2006 Jan-Feb;2(1):41-6; discussion 46-7. doi: 10.1016/j.soard.2005.10.006. Epub 2006 Jan 4. Surg Obes Relat Dis. 2006. PMID: 16925315
-
Concomitant cholecystectomy should be routinely performed with laparoscopic Roux-en-Y gastric bypass.Surg Endosc. 2015 Nov;29(11):3106-11. doi: 10.1007/s00464-014-4033-5. Epub 2014 Dec 17. Surg Endosc. 2015. PMID: 25515986
-
The Safety and Efficacy of Concurrent Laparoscopic Cholecystectomy during Minimally Invasive Roux-en-Y Gastric Bypass: A Systematic Review.Obes Surg. 2024 Jul;34(7):2650-2655. doi: 10.1007/s11695-024-07270-w. Epub 2024 May 20. Obes Surg. 2024. PMID: 38767785
-
The future of the Roux-en-Y gastric bypass.Expert Rev Gastroenterol Hepatol. 2016 Jul;10(7):777-84. doi: 10.1586/17474124.2016.1169921. Epub 2016 Apr 6. Expert Rev Gastroenterol Hepatol. 2016. PMID: 27027414 Review.
Cited by
-
Complicated gallstones after laparoscopic sleeve gastrectomy.J Obes. 2014;2014:468203. doi: 10.1155/2014/468203. Epub 2014 Jul 3. J Obes. 2014. PMID: 25105023 Free PMC article.
-
Comparative Analysis of the Incidence of Post-bariatric Cholelithiasis in Sleeve Gastrectomy and Roux-en-Y Gastric Bypass.Obes Surg. 2025 Aug;35(8):3157-3163. doi: 10.1007/s11695-025-08020-2. Epub 2025 Jul 7. Obes Surg. 2025. PMID: 40622468
-
Management of acute cholecystitis in cancer patients: a comparative effectiveness approach.Surg Endosc. 2014 May;28(5):1505-14. doi: 10.1007/s00464-013-3344-2. Epub 2014 Apr 1. Surg Endosc. 2014. PMID: 24687416
-
Management of biliary stones in bariatric surgery.Ther Adv Gastrointest Endosc. 2022 Jun 19;15:26317745221105087. doi: 10.1177/26317745221105087. eCollection 2022 Jan-Dec. Ther Adv Gastrointest Endosc. 2022. PMID: 36388729 Free PMC article. Review.
-
Gallstone Disease After Laparoscopic Sleeve Gastrectomy in an Asian Population-What Proportion of Gallstones Actually Becomes Symptomatic?Obes Surg. 2017 Sep;27(9):2419-2423. doi: 10.1007/s11695-017-2657-y. Obes Surg. 2017. PMID: 28401383
References
-
- Flegal KM, Carroll MD, Kuczmarski RJ, Johnson CL. Overweight and obesity in the United States: prevalence and trends, 1960–1994. Int J Obes Relat Metab Disord. 1998;22:39–47. - PubMed
-
- Brolin RE, Bradley LJ, Wilson AC, Cody RP. Lipid risk profile and weight stability after gastric restrictive operations for morbid obesity. J Gastrointest Surg. 2000;4:464–9. - PubMed
-
- Carson JL, Ruddy ME, Duff AE, Holmes NJ, Cody RP, Brolin RE. The effect of gastric bypass surgery on hypertension in morbidly obese patients. Arch Intern Med. 1994;154:193–200. - PubMed
-
- Choban PS, Onyejekwe J, Burge JC, Flancbaum L. A health status assessment of the impact of weight loss following Roux-en-Y gastric bypass for clinically severe obesity. J Am Coll Surg. 1999;188:491–7. - PubMed
-
- Foley EF, Benotti PN, Borlase BC, Hollingshead J, Black-burn GL. Impact of gastric restrictive surgery on hypertension in the morbidly obese. Am J Surg. 1992;163:294–7. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials